Isthmus Partners LLC cut its stake in DocGo Inc. (NASDAQ:DCGO - Free Report) by 20.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 638,028 shares of the company's stock after selling 161,268 shares during the period. Isthmus Partners LLC owned about 0.62% of DocGo worth $2,118,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Charles Schwab Investment Management Inc. raised its position in DocGo by 5.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 770,210 shares of the company's stock valued at $2,557,000 after purchasing an additional 40,150 shares in the last quarter. Intech Investment Management LLC acquired a new stake in DocGo in the third quarter valued at approximately $62,000. Victory Capital Management Inc. lifted its stake in DocGo by 100.3% in the third quarter. Victory Capital Management Inc. now owns 51,349 shares of the company's stock worth $170,000 after acquiring an additional 25,714 shares during the last quarter. GSA Capital Partners LLP grew its holdings in DocGo by 19.7% during the 3rd quarter. GSA Capital Partners LLP now owns 445,805 shares of the company's stock worth $1,480,000 after acquiring an additional 73,456 shares in the last quarter. Finally, WCM Investment Management LLC increased its position in shares of DocGo by 0.6% in the 3rd quarter. WCM Investment Management LLC now owns 2,626,971 shares of the company's stock valued at $8,879,000 after purchasing an additional 15,933 shares during the last quarter. 56.44% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
DCGO has been the subject of several recent analyst reports. Needham & Company LLC reaffirmed a "buy" rating and set a $7.00 price objective on shares of DocGo in a research report on Thursday, August 8th. Cantor Fitzgerald reaffirmed an "overweight" rating and set a $5.00 price objective on shares of DocGo in a research report on Friday, September 20th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, DocGo has a consensus rating of "Buy" and an average price target of $6.10.
Get Our Latest Stock Analysis on DCGO
DocGo Trading Down 1.1 %
Shares of NASDAQ DCGO traded down $0.05 during mid-day trading on Friday, reaching $4.33. The company had a trading volume of 521,852 shares, compared to its average volume of 992,822. The firm has a 50 day simple moving average of $3.63 and a two-hundred day simple moving average of $3.40. DocGo Inc. has a 52-week low of $2.75 and a 52-week high of $6.20. The stock has a market cap of $441.88 million, a P/E ratio of 15.46, a PEG ratio of 4.03 and a beta of 0.89.
DocGo Company Profile
(
Free Report)
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Featured Stories
Before you consider DocGo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.
While DocGo currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
